Becker’s Behavioral Health

Advertisement

The Latest

Nebraska’s Department of Health and Human Services has proposed eliminating 38 beds across two state psychiatric hospitals and closing a residential psychiatric treatment facility as part of an effort to reduce state spending, PBS and NPR affiliate Nebraska Public Media…

Behavioral healthcare M&A activity climbed in 2025, and transactions in 2026 suggest continuing activity across the sector.  Deal volume rose more than 42% in 2025 with 104 publicly announced transactions, compared to 73 in 2024 and 83 in 2023. Here…

Behavioral health needs continue to rise, yet many individuals face challenges finding the right care at the right time. Join Becker’s Healthcare and Cigna Healthcare for a discussion on innovative strategies to improve access, engagement, and outcomes through personalized provider…

Oct 22, 2026 1:00 PM – 2:00 PM CDT

Presented by:

Presented by
Presenters:
  • Stuart L. Lustig, MD, MPH, National Medical Executive for Behavioral Health Strategy and Product Design, Cigna Healthcare
  • Lisa Kay, Clinical Quality Leader, Evernorth Health Services
  • Anil Sipahimalani, MD, LFAPA, Lead Behavioral Medical Director, Enhanced Clinical Model, Cigna Healthcare
  • Jason Youngblood, Senior Director – Cigna US Markets Behavioral Center of Excellence and Sales Operations, Cigna Healthcare

From a 292-bed state-funded psychiatric hospital in Texas to New Mexico’s only children’s emergency psychiatric unit, hospitals and health systems are expanding behavioral health access as demand continues to grow, representing more than $730 million in investment. Here are 58…

For most health plans, social risk lives inside care management, disconnected from strategy and the balance sheet. The result is avoidable utilization no one has quantified and spending no one has traced to a cause. As medical costs climb and…

Oct 29, 2026 12:00 PM – 1:00 PM CDT

Presented by:

Presented by
Presenters:
  • April Richardson, MD, VP Clinical Services, BCBS South Carolina
  • Trenor Williams, MD, Chief Executive Officer, Socially Determined
  • James Beem, Senior Partner, Mathematica
  • David Wolf, SVP, Commercial Product, MedeAnalytics

A class of synthetic opioids known as orphines, some of which are estimated to be roughly 10 times more potent than fentanyl, has been detected in the illicit drug supply across 22 states, with detections increasing sharply since late 2025,…

The Drug Enforcement Administration is monitoring emerging threats from potent synthetic substances, including nitazenes and cychlorphine, that are being found mixed with fentanyl, according to the DEA’s “Emerging Drug Trends” guidance. Here are five things to know: 1. Law enforcement…

As the push to integrate behavioral health into primary and specialty care gains momentum, a number of health systems are appointing new leaders to oversee this transformation. These executives are tasked with aligning behavioral health strategies across clinical settings, building…

Advertisement
Advertisement